Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Boston Scientific | 46 | 0 | 13 | 0 | €68.50 | €73.05 | 6.638% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €69.00 | €79.43 | 15.115% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €463.30 | €543.72 | 17.358% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | €822.00 | €957.22 | 16.450% |
| Icon plc | 18 | 0 | 6 | 0 | €286.40 | €318.99 | 11.381% |
| Humana Inc. | 23 | 0 | 6 | 0 | €285.70 | €439.88 | 53.964% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €370.70 | €382.71 | 3.239% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 5 | 0 | €531.10 | €566.65 | 6.693% |
| Align Technology | 16 | 2 | 4 | 0 | €288.30 | €345.95 | 19.997% |
| Centene Corp. | 13 | 0 | 4 | 0 | €69.16 | €82.26 | 18.935% |
| Staar Surgical Co. | 11 | 1 | 4 | 0 | €44.12 | €49.02 | 11.101% |
| Intuitive Surgical Inc | 34 | 0 | 4 | 0 | €350.15 | €370.00 | 5.669% |
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | €688.70 | €753.63 | 9.428% |
| Sutro Biopharma Inc | 18 | 0 | 4 | 0 | €3.14 | €11.05 | 251.860% |
| Resmed Inc. | 19 | 0 | 4 | 0 | €198.75 | €207.72 | 4.511% |
| Biogen Inc. | 44 | 2 | 4 | 1 | €194.00 | €294.45 | 51.778% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €100.30 | €116.81 | 16.458% |
| Stryker Corp. | 17 | 0 | 4 | 0 | €313.60 | €331.52 | 5.716% |
| Heron Therapeutics Inc. | 9 | 1 | 3 | 0 | €2.29 | €4.57 | 99.381% |
| Novo Nordisk A/S ADR | 17 | 1 | 3 | 0 | €119.00 | €130.44 | 9.612% |
| Amgen Inc. | 22 | 0 | 3 | 0 | €252.00 | €294.28 | 16.779% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €371.30 | €421.61 | 13.548% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €145.15 | €173.22 | 19.338% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €13.58 | €20.00 | 47.275% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €126.55 | €137.63 | 8.759% |